Researchers based in Germany have developed a perfusion process for the manufacture of oncolytic viruses. The team from the Max Planck Institute says that the new approach aims to improve virus titers ...
In a recent review, Trent Munro, PhD, National Biologics Facility, University of Queensland, Australia, writes that “Improvements in process and cell line development, the advent of single-use ...
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
SUZHOU, China and HANGZHOU, China, Sept. 15, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company, today announced success in scaling up the continuous perfusion process to 200L and ...
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc.
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the ambr ® 250 high throughput (ht) perfusion, a new automated ...
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Perfusion technology was first introduced in the late 1980s to boost the low product ...
Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Perfusion technology was first introduced in the late 1980s to boost the low product ...
908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resilience), a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results